Eikon Therapeutics, Inc. Common Stock — Institutional Ownership

Which tracked institutions hold EIKN, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.

15
Funds holding
$95185885
Total value held
Buying
11 added/new · 2 reduced
# Institution Value Shares Δ Shares Change (QoQ)
1 Blackrock, Inc. $55872596 4281425 +962046 +28.98%
2 Merck & Co., Inc. $21749991 1666666 Held
3 State Street Corp $4620914 354093 +313943 +781.93%
4 Franklin Resources Inc $4567500 350000 Held
5 Ubs Group Ag $3444313 263932 +263932 NEW BUY
6 Northern Trust Corp $2295847 175927 +130396 +286.39%
7 Invesco Ltd. $664245 50900 +50900 NEW BUY
8 Bank Of New York Mellon Corp $623634 47788 +47788 NEW BUY
9 Bank Of America Corp /De/ $490354 37575 -48559 -56.38%
10 Wells Fargo & Company/Mn $252491 19348 +19348 NEW BUY
11 Citigroup Inc $218966 16779 +16779 NEW BUY
12 Morgan Stanley $157019 12032 -3241 -21.22%
13 Jpmorgan Chase & Co $131528 10324 +9024 +694.15%
14 Barclays Plc $60487 4635 +4317 +1357.55%
15 Royal Bank Of Canada $36000 2784 +2784 NEW BUY

Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.